BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BET Inhibition-Induced GSK3β Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors

Published:2018-08 Issue:8 Volume:24 Page:2155-2166
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Derenzini Enrico,Mondello Patrizia,Erazo Tatiana,Portelinha Ana,Liu Yuxuan,Scallion Mary,Asgari Zahra,Philip John,Hilden Patrick,Valli Debora,Rossi Alessandra,Djaballah Hakim,Ouerfelli Ouathek,de Stanchina Elisa,Seshan Venkatraman E.,Hendrickson Ronald C.,Younes Anas

Funder

MSK SPORE

Vogelstein Fund for Lymphoma Research

Memorial Sloan Kettering Cancer Center Core

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference47 articles.

1. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3);Beurel;Trends Immunol.,2010

2. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases;Beurel;Pharmacol. Ther.,2015

3. The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs;Boi;Clin. Cancer Res.,2015

4. How APC/C orders destruction;Buschhorn;Nat. Cell Biol.,2006

5. Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors;Ceribelli;Proc. Natl. Acad. Sci. USA,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BET bromodomain inhibitors PFI-1 and CPI-203 suppress the development of follicular lymphoma via regulating Wnt/β-catenin signaling;Heliyon;2024-03

2. Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy;Signal Transduction and Targeted Therapy;2023-11-06

3. A Ferroptosis-Related Prognostic Model of Mantle Cell Lymphoma;2023-10-03

4. Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies;Leukemia & Lymphoma;2023-09-14

5. Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML;Clinical Cancer Research;2023-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3